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ABSTRACT Listeria monocytogenes can cause a life-threatening illness when the food-
borne pathogen spreads beyond the intestinal tract to distant organs. Many aspects of
the intestinal phase of L. monocytogenes pathogenesis remain unknown. Here, we pres-
ent a foodborne infection model using C57BL/6 mice that have been pretreated with
streptomycin. In this model, as few as 100 L. monocytogenes CFU were required to cause
self-limiting enterocolitis, and systemic dissemination followed previously reported
routes. Using this model, we report that listeriolysin O (LLO) and actin assembly-
inducing protein (ActA), two critical virulence determinants, were necessary for intes-
tinal pathology and systemic spread but were dispensable for intestinal growth. Se-
quence tag-based analysis of microbial populations (STAMP) was used to investigate
the within-host population dynamics of wild-type and LLO-deﬁcient strains. The
wild-type bacterial population experienced severe bottlenecks over the course of in-
fection, and by 5 days, the intestinal population was highly enriched for bacteria
originating from the gallbladder. In contrast, LLO-deﬁcient strains did not efﬁciently
disseminate and gain access to the gallbladder, and the intestinal population re-
mained diverse. These ﬁndings suggest that systemic spread and establishment of a
bacterial reservoir in the gallbladder imparts an intraspecies advantage in intestinal
occupancy. Since intestinal L. monocytogenes is ultimately released into the environ-
ment, within-host population bottlenecks may provide purifying selection of viru-
lence genes.
IMPORTANCE Listeria monocytogenes maintains capabilities for free-living growth in
the environment and for intracellular replication in a wide range of hosts, including live-
stock and humans. Here, we characterized an enterocolitis model of foodborne L. mono-
cytogenes infection. This work highlights a multiorgan trafﬁcking circuit and reveals a ﬁt-
ness advantage for bacteria that successfully complete this cycle. Because virulence
factors play critical roles in systemic dissemination and multiple bottlenecks occur as the
bacterial population colonizes different tissue sites, this multiorgan trafﬁcking circuit
likely provides purifying selection of virulence genes. This study also serves as a founda-
tion for future work using the L. monocytogenes-induced enterocolitis model to investi-
gate the biology of L. monocytogenes in the intestinal environment.
KEYWORDS Listeria monocytogenes, STAMP, gastrointestinal infection, intracellular
bacteria, pathogenesis
The Gram-positive bacterium Listeria monocytogenes occupies a wide ecologicalniche that facilitates its entry into our food system. Upon ingestion, L. monocyto-
genes infects a broad range of hosts, including livestock and humans. In healthy adults,
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L. monocytogenes infection leads to self-limiting enterocolitis which usually does not
require clinical attention, making accurate counts of L. monocytogenes infections
difﬁcult (1). In rare instances, L. monocytogenes leads to listeriosis, a systemic disease
that often includes bacteremia and meningoencephalitis, and can lead to pregnancy
loss (2). Risk factors for the development of listeriosis include compromised immunity
and pregnancy. Although treatments are available, mortality rates remain near 25% (3).
The pathogenesis of L. monocytogenes depends on host cell entry, escape from the
entry vacuole, intracellular replication, and spread to systemic sites. By secreting
listeriolysin O (LLO), a pore-forming cytolysin encoded by the hly gene, L. monocyto-
genes disrupts the entry vacuole and enters the host cytosol where it replicates rapidly.
Strains lacking LLO cannot access the host cytosol and thus fail to replicate intracellu-
larly (4). Shortly after entering the host cytosol, actin assembly-inducing protein (ActA)
decorates the bacterial surface and induces actin polymerization to propel the bacte-
rium, ﬁrst intracellularly and then to facilitate spread from one cell to the next. Strains
lacking ActA replicate in the host cytosol but have a defect in spreading to adjacent
cells. In mice, intravenous (i.v.) infection with strains lacking either LLO or ActA result
in severely attenuated growth at sites of dissemination (4–8). Following initial infection
of host cells in the intestinal epithelium, the pathogen eventually breaches the intes-
tinal barrier and spreads to systemic sites in two waves. Within the ﬁrst 24 h of infection,
the ﬁrst wave of bacteria arrives in the liver via the portal vein. The second wave
spreads from mesenteric lymph nodes to the spleen. These two populations then
intermix by exchange through the circulatory system (9). L. monocytogenes in the liver
subsequently enters the gallbladder and replicates extracellularly to a high density (10).
Upon bile excretion, L. monocytogenes reenters the intestinal tract and is shed in feces.
Thus, during infection, the gallbladder can be transformed into a bacterial reservoir
(11).
Both mice and humans are relatively resistant to orally acquired L. monocytogenes
infections. Estimates suggest that the average person consumes L. monocytogenes-
contaminated food 5 to 9 times a year, yet the reported incidence of listeriosis is orders
of magnitude lower (12). Although the minimal infectious dose for L. monocytogenes in
humans is unknown, a L. monocytogenes outbreak caused by contaminated chocolate
milk suggested that a dose of approximately 3 1011 CFU led to the development of
febrile gastroenteritis in healthy adults (13). Over the past few decades, the most widely
studied animal model of L. monocytogenes pathogenesis has been the mouse i.v.
infection model. The i.v. model approximates the more severe systemic form of the
disease but completely bypasses the initial intestinal phase of the infection. Due in part
to this limitation, L. monocytogenes biology within the intestinal tract remains incom-
pletely deﬁned. In C57BL/6 mice, administration of doses as high as 1 108 CFU lead
to L. monocytogenes recovered from feces and dissemination to systemic sites, but
obvious signs of disease do not develop (14). These observations suggest that resis-
tance mechanisms effectively control L. monocytogenes following ingestion. In other
mouse models of disease caused by enteric pathogens, including Salmonella enterica
serovar Typhimurium, Citrobacter rodentium, and Clostridium difﬁcile, antibiotic treat-
ment of mice prior to infection increases susceptibility to infection (15–17). Similarly,
oral gavage of streptomycin 24 h prior to an oral gavage of L. monocytogenes dramat-
ically enhances intestinal colonization (18).
Here, we describe a foodborne mouse model of L. monocytogenes-induced entero-
colitis and ﬁnd that the intracellular life cycle of L. monocytogenes is dispensable for
growth in the intestinal tract but required for host pathology. Moreover, characteriza-
tion of L. monocytogenes population dynamics in the intestinal tract revealed an
intraspecies competition between intestine-resident and systemically derived bacteria.
As the infection progressed, the majority of L. monocytogenes shed in feces originated
from the gallbladder. Notably, this intraspecies competition did not arise in mice
infected with an LLO-deﬁcient strain, suggesting that this multiorgan trafﬁcking circuit
required LLO and that successful completion of the circuit imparts a ﬁtness advantage.
Collectively, our results demonstrate that the L. monocytogenes-induced enterocolitis
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model provides an exciting opportunity to study L. monocytogenes pathogenesis in the
intestinal tract.
RESULTS
Streptomycin pretreatment increases susceptibility to foodborne Listeria
monocytogenes infection. In our efforts to advance our understanding of L. monocy-
togenes pathogenesis, we modiﬁed a previously described foodborne model of L.
monocytogenes infection where mice voluntarily consume a breadcrumb containing a
deﬁned number of bacteria (14). In contrast to oral gavage, this foodborne method of
infection rules out possible injury during inoculation, which can lead to inadvertent
systemic dissemination. One limitation of the foodborne method is the relatively high
resistance of C57BL/6 mice to L. monocytogenes infection compared to that of other
inbred mouse strains (14). Becattini et al. reported that antibiotic treatment of mice
prior to infection dramatically increases susceptibility to orally acquired L. monocyto-
genes (18). We tested whether streptomycin (Sm) pretreatment affected foodborne L.
monocytogenes infection in C57BL/6 mice. To noninvasively administer the antibiotic,
we added 5 mg/ml streptomycin to the mouse drinking water 48 h prior to infection.
Groups of Sm- and mock-treated female C57BL/6 mice were fasted overnight and
individually fed a breadcrumb contaminated with 1 108 CFU of the Sm-resistant L.
monocytogenes strain 10403S. Immediately after the mice consumed the breadcrumb,
they were returned to cages with ad libitum access to standard mouse chow and
standard drinking water. To measure intestinal colonization, we enumerated L. mono-
cytogenes CFU shed in the mouse feces over the course of 5 days (Fig. 1A). Relative to
mock-treated mice, there was a million-fold increase in L. monocytogenes CFU from the
Sm-pretreated mice (Sm mice). The Sm mice continued to shed upwards of 1 108
CFU/gram during the 5-day observation period, whereas almost all of the mice in the
mock-treated group remained just above the limit of detection. As a gross metric of
disease severity, we monitored body weight over the course of infection (Fig. 1B). The
weights of mice that received only Sm (see Fig. S1 in the supplemental material) and
mice that were mock treated but infected with L. monocytogenes remained stable over
the observation period. In contrast, Sm mice that received L. monocytogenes began to
lose weight 3 days postinfection and lost 15% to 20% of their initial body weight
by 4 days postinfection. At 5 days postinfection, Sm mice began to regain weight.
In conjunction with weight loss, Sm mice also developed acute diarrhea reminiscent
of the self-limiting gastroenteritis that L. monocytogenes causes in humans (see
Fig. S2).
To examine the effect of streptomycin pretreatment on systemic dissemination after
foodborne infection, mice were sacriﬁced 5 days postinfection and L. monocytogenes
CFU were enumerated in the gastrointestinal tract, mesenteric lymph nodes, spleen,
liver, and gallbladder (Fig. 1C). In all tissues examined, Sm mice contained signiﬁcantly
more CFU than mock-treated mice. Although previous studies of intestinal L. monocy-
togenes infections focused on the small intestine, the majority of recoverable L.
monocytogenes CFU were found in the cecum and colon, where the pathogen burden
exceeded that in control animals by 5 orders of magnitude. In stark contrast to the
gallbladders from control mice, where L. monocytogenes was not detectable, all the
gallbladders of Sm mice contained 106 CFU (Fig. 1C).
To test if lower doses of L. monocytogenes also lead to disease, Sm mice were fed
breadcrumbs containing 10, 100, or 1,000 CFU and monitored for changes in body
weight and for shedding of L. monocytogenes in feces. The body weight of mice
receiving 10 bacteria remained stable and L. monocytogenes was not detected in feces.
However, inocula of only 100 bacteria led to weight loss during the course of infection
(Fig. 1D). The amount of L. monocytogenes recovered from feces increased from 104
CFU/g on day 1 to 1 109 CFU/g by 3 days postinfection, indicating that L. monocy-
togenes robustly replicates within the streptomycin-pretreated intestines (Fig. 1E).
Together, streptomycin pretreatment followed by foodborne infection with L. mono-
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cytogenes in C57BL/6 mice provide an excellent opportunity to examine the intestinal
phase of L. monocytogenes pathogenesis in a genetically tractable host.
Characterization of L. monocytogenes dissemination over the course of infec-
tion. To evaluate the dynamics of L. monocytogenes systemic spread in this model, Sm
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FIG 1 Streptomycin pretreatment enhances susceptibility of mice to foodborne L. monocytogenes (Lm)
infection. (A) L. monocytogenes fecal shedding. C57BL/6 mice (n 5) received either no treatment or
streptomycin (Sm)-supplemented drinking water for 48 h prior to infection by voluntary consumption of
bread containing 108 L. monocytogenes CFU. Results are expressed as log-transformed CFU per gram of feces.
Lines represent individual mice. Treatment: P 0.001 (two-way analysis of variance [ANOVA]). (B) Body weight
of mice in panel A. Results are expressed as a percentage of body weight prior to streptomycin treatment.
Lines represent individual mice. Treatment: P  0.001 (two-way ANOVA). (C) Bacterial burden 5 days
postinfection of mice in panel A. Results are expressed as log-transformedmeans with standard errors. ***, P
0.001 by unpaired two-sided t test. Dashed lines indicate limits of detection. (D) Body weights of mice
receiving Sm and either 10, 100, or 1,000 L. monocytogenes CFU as described for panel A. Results are expressed
as a percentage of body weight prior to streptomycin treatment, and means with standard errors are
indicated. Two-way ANOVA, dose, P  0.05; Bonferroni’s posttest, 10 versus 100, day 5: P  0.001; 10 versus
1,000, day 5: P  0.01). (E) L. monocytogenes fecal shedding in mice in panel D. Results are expressed as
log-transformed means with standard errors. Two-way ANOVA, dose, P  0.001; Bonferroni’s posttest, 10
versus 100, day 2: P  0.001; 10 versus 1,000, day 2: P  0.001). Dashed line indicates limit of detection. All
results are representative of at least 2 independent experiments.
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mice were infected with 108 CFU of foodborne L. monocytogenes, and cohorts of mice
were sacriﬁced every 24 h to enumerate pathogen burden in the intestines, mesenteric
lymph nodes, liver, gallbladder, and spleen. At 24 h postinfection, L. monocytogenes was
recovered throughout the intestinal tract, with 108 CFU/g in the ileum and 1010
CFU/g in the cecum and colon (Fig. 2A and B). The pathogen burden remained fairly
stable over the course of 5 days. In intestinal tissue, the L. monocytogenes population
was comprised of extracellular bacteria in the intestinal lumen and bacteria within host
cells. To determine the fraction of intracellular bacteria, ceca were washed with
phosphate-buffered saline (PBS) and treated with gentamicin prior to CFU enumera-
tion, as gentamicin does not affect intracellular bacteria. We focused on the cecum due
to the high abundance of bacteria. At 24 h postinfection, 104 gentamicin-resistant
CFU per organ were recovered from the cecum, indicating that intracellular bacteria
represented a very minor fraction of the total pathogen burden in the intestine and
suggesting that host cell entry occurred infrequently. Over 5 days, the intracellular
population increased 10-fold (Fig. 2B).
L. monocytogenes were detectable at systemic sites as soon as 24 h postinfection.
Among the systemic sites monitored, the liver had the highest bacterial burden at 24 h
postinfection (104 CFU per organ) (Fig. 2C and D), which is consistent with a model
where the liver receives the ﬁrst wave of bacteria via the portal vein (9). Because the
gallbladder was previously reported to contain a reservoir of L. monocytogenes, we
enumerated CFU in the gallbladder separately from the liver. During the ﬁrst 3 days of
infections, gallbladders contained roughly 10-fold fewer bacteria than the liver. How-
ever, by day 4, gallbladder CFU increased 10,000-fold, and bacterial burdens in the
gallbladder surpassed those in the liver by 10-fold on days 4 and 5 postinfection.
The dynamics of L. monocytogenes dissemination to mesenteric lymph nodes (mLN)
and spleen differed from those observed in the liver. One day postinfection, CFU in the
mLN and spleen were 1,000-fold lower than in the liver (Fig. 2D). On day 2, CFU in the
mLN increased 10,000-fold and plateaued over the course of the experiment. In
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FIG 2 L. monocytogenes tissue colonization dynamics. C57BL/6 mice received Sm pretreatment and
bread contaminated with 108 L. monocytogenes CFU. Cohorts of mice (n 10) were sacriﬁced at 24-h
intervals, and bacterial burdens were determined. Results are expressed as log-transformed CFU per
gram or organ as indicated, and data are combined from 2 independent experiments. (A) Colon and
ileum CFU per gram of tissue. (B) Cecum CFU. Total L. monocytogenes CFU per gram and gentamicin-
resistant L. monocytogenes CFU per organ are presented. (C) Liver and gallbladder CFU. (D) Mesenteric
lymph node and spleen CFU. Dashed lines indicate limits of detection.
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contrast, we observed a steady 10-fold increase/day in the spleen over 4 days, but on
day 5, a 10-fold decrease was observed. These observations are consistent with a
second wave of L. monocytogenes dissemination from the mLN to the spleen as
described in the guinea pig model (9). Taken together, the routes and dynamics of
systemic spread in this model are consistent with previous reports (9, 11).
LLO and ActA are required for intestinal pathology and systemic dissemina-
tion.We investigated the roles of two well-established and well-characterized virulence
determinants, LLO and ActA, on the intestinal phase of L. monocytogenes pathogenesis.
Groups of C57BL/6 mice were pretreated with streptomycin and infected with 108
wild-type (WT), ΔactA, or Δhly strains. In contrast to the WT strain, neither of the mutant
strains led to weight loss in infected mice (Fig. 3A), even though the numbers of CFU
of both mutant strains recovered in feces were similar to that for the WT for the ﬁrst
3 days of infection (Fig. 3B). Compared to the WT strain, which caused goblet cell loss,
submucosal edema, severe inﬂammation characterized by prominent multifocal sub-
mucosal cellular inﬁltrate, and loss of epithelial integrity marked by epithelial erosion
and ulceration, the ΔactA or Δhly strain caused little colonic pathology (Fig. 3C and D).
Furthermore, the two mutants were markedly attenuated in their capacity to dissem-
inate beyond the intestine (Fig. 3E). However, small numbers of bacteria were still
recoverable from mesenteric lymph nodes, spleens, and livers of mice infected with
either mutant strain, indicating that there are hly- and actA-independent mechanisms
of spread. At least part of the reduced capacity of the Δhly strain to spread and cause
disease may be attributable to its diminished ability to enter or proliferate in intestinal
cells; the quantity of intracellular bacteria (gentamicin-resistant CFU) in the ceca of
animals infected with the Δhly strain was 1,000-fold lower than observed with the WT
strain (data not shown).
Clonal enrichment of intestinal population depends upon systemic dissemina-
tion. The observation that the hly strain did not have a detectable defect in fecal
shedding led us to investigate how intracellular replication and systemic spread
modiﬁes the population dynamics of this enteric pathogen. As L. monocytogenes
spreads systemically, a reservoir of extracellular bacteria develops in the gallbladder;
these bacteria can then reenter the intestinal tract during bile excretion and be shed in
the feces (10, 11). Given that the hly strain had a marked defect in accessing and/or
proliferating in the gallbladder, we hypothesized that the hly strain would be unable
to complete this within-host trafﬁcking route, which could negatively impact fecal
transmission in a natural setting. To explore this hypothesis, we generated a collection
of 200 genetically tagged but otherwise isogenic strains of wild-type and Δhly L.
monocytogenes and tracked the presence and frequency of tags in the feces over the
course of the infection and in the gallbladder at 5 days postinfection.
In Sm mice infected with wild-type L. monocytogenes, the tag abundances recovered
from fecal samples collected 1 and 2 days postinfection closely resembled the abun-
dances found in the inoculum (see Fig. S3). By day 3, the fecal L. monocytogenes
population structures began to deviate from the input population, which coincided
with the onset of diarrhea and weight loss in the animal (Fig. 1B and S2). By day 5, we
observed an enrichment of 1 or 2 tags in the fecal L. monocytogenes population (Fig. 4A
and S3A). In two of ﬁve samples (mouse 1 and 3),80% of the bacteria recovered from
the feces shared the same genetic tag. In the remaining three samples, one or two tags
accounted for approximately 40% of the bacterial population. Strikingly, the domi-
nant tags found in the day-5 fecal populations matched the tags found in the
gallbladder, which was predominantly populated with L. monocytogenes sharing 1 or 2
tags (Fig. 4A and B and S3A). The identity of fecal and gallbladder L. monocytogenes
tags strongly suggested that by day 5 of infection, gallbladder-resident bacteria reen-
tered and outcompeted the L. monocytogenes already present in the intestinal tract.
Importantly, the identity of dominant tags recovered from feces and gallbladder
differed between mice, ruling out the possibility that our tagged library contained a
strain with improved host colonization. These observations are consistent with a
previous study that used BALB/c mice and an InlAm strain of L. monocytogenes (11). In
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Sm mice infected with the Δhly strain, the tag abundances in fecal samples remained
fairly stable and closely resembled the input population over the course of 5 days
(Fig. 4C and S3B). Animals infected with the Δhly strain had no or few L. monocytogenes
CFU recovered from their gallbladders, making assessment of pathogen population
structures at this site infeasible.
To quantify changes in population structures, we calculated a relatedness score
based on changes in tag abundances found in feces 5 days postinfection compared to
abundances found in the inoculum (Fig. 4D and S4C and D). The relatedness score of
the Δhly populations recovered from mice 5 days postinfection was 0.85, indicating that
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FIG 3 L. monocytogenes-induced intestinal pathology and systemic spread requires LLO and ActA. C57BL/6
mice received Sm pretreatment and bread contaminated with 108 CFU of either wild-type, Δhly, or ΔactA
strains. (A) Body weights. Results are expressed as a percentage of body weight prior to streptomycin
treatment. Two-way ANOVA and Bonferroni’s posttest, WT versus Δhly, days 2 to 5: P  0.05; WT versus
ΔactA, days 2 to 5: P  0.05 (B) Fecal shedding. Results are expressed as log-transformed means with
standard errors. Two-way ANOVA and Bonferroni’s posttest, WT versus Δhly, days 1 to 5: P 0.05; WT versus
ΔactA, day 5: P  0.01. (C) Representative hematoxylin and eosin staining of colonic tissues. Scale bars, 500
M. Sites of edema are indicated by asterisks, and sites of immune cell inﬁltrate are indicated by arrows.
(D) Combined pathology scores. Bars represent individual animals with statistically signiﬁcant differences
compared to mice with the wild-type strain. ***, P  0.001 by one-way ANOVA and Dunnett’s posttest. (E)
Bacterial burdens. Results are expressed as log-transformed means with standard errors. ***, P  0.001
versus mice infected with the wild type strain, one-way ANOVA and Dunnett’s posttest. Data are combined
from two independent experiments.
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the population remained highly similar to the inoculum. In contrast, the relatedness
score was 0.44 for the wild-type populations recovered from mice 5 days postinfection
(Fig. 4D and S4C and D). Together, the absence of clonal enrichment in fecal samples
recovered from infections with the Δhly strain along with the enrichment of
gallbladder-derived bacteria in infections with the wild-type strain support a model
where LLO-dependent systemic spread leads to the establishment of a bacterial
reservoir in the gallbladder which becomes the dominant bacteria population shed in
feces.
DISCUSSION
L. monocytogenes infection begins through the consumption of contaminated food,
yet the i.v. infection of mice remains the most widely used in vivo model of L.
monocytogenes pathogenesis. Here, we describe a noninvasive and genetically tractable
mouse model of foodborne infection that leads to the development of intestinal
pathology as well as systemic dissemination. During the course of infection, bacteria
disseminated from the intestinal tract to systemic sites, including the spleen, liver, and
gallbladder. Following the proliferation of a very small number of founding bacterial
cells (often one) to high densities in the gallbladder (11), L. monocytogenes reentered
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FIG 4 Within-host population dynamics of wild-type and Δhly strains. C57BL/6 mice (n 5) received Sm
pretreatment and bread contaminated with 108 CFU of a L. monocytogenes library containing 200
genetically tagged strains. Relative tag abundance from 5 days postinfection. Individual tags are indi-
cated by different colors. (A) Fecal pellets recovered from mice infected with the wild-type strain. (B)
Gallbladders. Same mice as in panel A. (C) Fecal pellets recovered from mice infected with a Δhly strain.
(D) Genetic relatedness of organisms recovered from fecal pellets 5 days postinfection relative to their
respective inocula. A score of 1 indicates no divergence from the inocula. **, P  0.01 by unpaired
two-tailed t test.
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the intestinal tract through the bile duct, and these bacteria, which had undergone
replication at systemic sites, outcompeted their intestine-resident counterparts. L.
monocytogenes lacking LLO or ActA proliferated in the intestines but was highly
impaired in its capacity to complete this multiorgan trafﬁcking circuit. Thus, the ability
to complete its intracellular life cycle may confer an advantage in environmental
dispersion for L. monocytogenes.
Compared to other small animal models of L. monocytogenes infection, the food-
borne enterocolitis model presented here has several advantages. This model offers a
system that utilizes the natural route of infection, the genetically tractable C57BL/6
mouse genetic background, and infectious doses as low as 100 CFU. These attributes
facilitate experiments aimed at understanding L. monocytogenes biology in the intes-
tinal environment, host factors involved in the initial phase of infection, and bacterial
determinants of intestinal pathogenesis. In comparison to a previously described
foodborne model (14), the enterocolitis model leads to more severe disease marked by
weight loss, acute diarrhea, inﬂux of immune cells into intestinal tissues, and fecal
shedding of up to 109 CFU/g. Notably, monitoring weight loss during infection is a fairly
simple approach for quantifying disease severity. The high number of L. monocytogenes
cells recovered from feces provides a wide dynamic range for characterizing factors
involved in intestinal colonization. Given the very large number of C57BL/6 mutant
mice and immunological tools available for L. monocytogenes infection in mice, the
enterocolitis model is an attractive system for the study of mucosal immunology.
An important confounding feature of the enterocolitis model is the streptomycin
pretreatment. Because streptomycin treatment alters the composition of the microbi-
ota, this model will have limited use for probing interactions between L. monocytogenes
and an intact microbiota. Furthermore, the downstream consequences of dysbiosis
induced by streptomycin treatment, such as disruption of the hypoxic state within
intestinal tissues (19), can complicate interpretations of ﬁndings from this model.
Another potential limitation of the enterocolitis model is that internalin A (InlA)-
dependent mechanisms of pathogenesis may not apply in this setting, because mouse
E-cadherin and InlA have weak interactions (20, 21); however, dissemination in the
enterocolitis model appears to follow the route described in the guinea pig model,
where interactions between InlA and E-cadherin play a role (9). Despite these limita-
tions, this model will aid our efforts to understand the molecular mechanisms of L.
monocytogenes pathogenesis.
The roles of LLO and ActA during the systemic phase of L. monocytogenes infection
have been extensively characterized, and absence of either virulence factor leads to
severe attenuation in the i.v. mouse model (4, 5). The characterization of LLO and ActA
in the development of enterocolitis presented here complements the existing literature
on LLO and ActA in the intestinal setting. We report that infection with wild-type but
neither Δhly nor ΔactA L. monocytogenes resulted in intestinal inﬂammation, diarrhea,
and weight loss. These observations are consistent with studies in germfree mice,
where administration of a Δhly strain did not trigger immune cell inﬁltration of
intestinal tissues (22). Similarly, formerly germfree mice colonized with a ΔactA strain
remained disease free for up to 90 days postinfection (23). Together, these ﬁndings
suggest that the recruitment of immune cells to intestinal tissues and the subsequent
development of pathology require the intact L. monocytogenes intracellular life cycle. In
the enterocolitis model described in this study, both LLO and ActA were required for
robust systemic dissemination. Similar ﬁndings have been reported in studies of
germfree mice and in mice with intact microbiota (22, 24). This defect in systemic
spread could be explained by a reduced capacity of the mutants to cross the intestinal
barrier and/or poor survival at systemic sites, as previously observed in studies using
the i.v. infection model (6–8).
Importantly, the differences in pathology and systemic dissemination between mice
infected with wild-type, Δhly, and ΔactA strains could not be explained by differences
in the intestinal abundance of these strains. In the enterocolitis model, mice infected
with wild-type and Δhly strains shed comparable levels of L. monocytogenes in feces
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over the course of the study. Studies in a germfree setting and in the presence of an
intact microbiota yielded similar ﬁndings for a Δhly strain, suggesting that intestinal
colonization does not require LLO and that luminal L. monocytogenes was not sufﬁcient
to cause disease (22, 24). Mice infected with the ΔactA strain shed almost 50-fold less
L. monocytogenes than mice infected with the wild type at 5 days postinfection, which
may be due to the role of ActA in bacterial aggregate formation during intestinal
carriage (25). Alternatively, given the reported vaccination efﬁcacy of the ΔactA strain
(6, 26) and the late onset of the difference in fecal shedding, the potential contribution
of the host adaptive immune response in controlling bacterial growth in the intestinal
tract under these conditions warrants further investigation.
Successful enteric pathogens utilize strategies to subvert colonization resistance
mechanisms imposed by the intestinal microbiota (27). Colonization resistance mech-
anisms are successful against incoming L. monocytogenes, as demonstrated by the
effectiveness of streptomycin pretreatment in enabling the growth of L. monocytogenes
in the intestine (18). However, it has been proposed that intestinal microbiota compo-
sition could represent an important risk factor for listeriosis, given that physiological
conditions often associated with increased risk of severe listeriosis such as advanced
age, pregnancy, and compromised immunity are also associated with changes to
microbiota composition (28). Although the mechanisms by which the intestinal micro-
biota inhibits L. monocytogenes colonization remain unknown, members of the Clos-
tridiales are sufﬁcient for protection (18). Despite these defenses, L. monocytogenes
overcomes colonization resistance and causes disease, yet the mechanisms by which
this occurs remain incompletely deﬁned. One strategy is seen in a subset of outbreak-
associated L. monocytogenes strains that use a bacteriocin called listeriolysin S to
directly limit competing bacteria in the intestine (29). As the infection progresses,
gallbladder colonization could provide an alternative strategy that minimizes the need
to directly compete with the intestinal microbiota. By replicating to densities as high as
107 per gallbladder, the intestinal tract acts as a conduit for release into the environ-
ment, where L. monocytogenes can grow as a free-living saprophyte until encountering
a suitable host. The experiments presented here do not directly address the mecha-
nisms by which the gallbladder population gains an advantage over intestine-resident
counterparts. Perhaps diarrhea during infection creates an environment in which
incoming L. monocytogenes from the gallbladder displaces intestine-resident bacteria.
Another possibility is that exposure to the gallbladder environment induces adaptive
responses in L. monocytogenes that promote survival and/or growth in the intestines.
Notably, another enteric facultative intracellular pathogen Salmonella Typhi has inde-
pendently evolved a similar strategy. Presence of S. Typhi in the gallbladder has been
linked to the development of asymptomatic carriers such as Mary Mallon, or “Typhoid
Mary,” which play critical roles in transmission (30, 31).
The biphasic lifestyle of L. monocytogenes necessitates the maintenance of genes
required for growth as a free-living saprophyte and those required for growth as an
intracellular pathogen. Gaps remain in our understanding of how these two programs
are maintained. Activation of virulence genes under soil-mimicking conditions leads to
a loss in competitiveness (32). However, the hly gene which encodes LLO appears to be
under purifying selection, because the ratio of nonsynonymous to synonymous sub-
stitutions (dN/dS) estimated for hly (dN/dS 0.03674) is similar to that of core genes
(dN/dS 0.05353) (33). Additionally, of 57,820 isolates of L. monocytogenes from the
environment, only 5 contained mutations in hly (33). In this study, an intraspecies
competition developed between intestine-resident and gallbladder-derived bacteria,
with the gallbladder-derived bacteria eventually becoming dominant in feces. This also
occurs in animals with intact microbiota, suggesting that the intraspecies competition
did not arise due to alterations in intestinal niches resulting from streptomycin treat-
ment (11). Since very few L. monocytogenes cells ultimately seed the gallbladder (8,
10)—representing a severe population bottleneck—and gallbladder colonization fol-
lowing foodborne infection requires LLO and ActA, these within-host bottlenecks
provide purifying selection to maintain the integrity of the virulence program and
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suggest that host association plays a key role in the life history of L. monocytogenes.
Thus, our work offers insight into how evolutionary forces that promote the virulence
of this facultative intracellular pathogen can promote its presence in the environment.
MATERIALS AND METHODS
Ethics statement. This study was carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Research Council of the National
Academy of Sciences (34). All protocols were reviewed and approved by the Animal Care and Use
Committee at the University of California, Berkeley (AUP-2016-05-8811).
Bacterial strains and growth conditions. All L. monocytogenes strains used in this study were
derived from wild-type 10403S (Table 1) and propagated in ﬁlter-sterilized brain heart infusion (BHI)
medium (BD) at 37°C with shaking and without antibiotics unless otherwise stated in Materials and
Methods. Cell density was spectrophotometrically measured by optical density at a wavelength of
600 nm (OD600). Frozen bacterial stocks were stored at 80°C in BHI medium plus 40% glycerol. Culture
medium supplements were used at the following concentrations: streptomycin at 200 g/ml, chloram-
phenicol at 7.5 g/ml, nalidixic acid at 15 g/ml, LiCl at 6 mg/ml, and glycine at 6 mg/ml.
Plasmid and strain construction. Escherichia coli strains used in this study are listed in Table 1. For
vector construction, plasmids were maintained in E. coli DH5. Plasmids were introduced into L.
monocytogenes by conjugation as previously described, using a donor E. coli SM10 and a compatible L.
monocytogenes strain (35). Barcoded L. monocytogenes libraries were constructed as previously described
using pTZ200.mix (11), a pooled plasmid library containing 200 unique barcodes assembled onto a pPL2
backbone which stably integrates into the L. monocytogenes chromosome (35).
Mice. C57BL/6 mice were purchased from the Jackson Laboratory and maintained under speciﬁc-
pathogen-free conditions at the University of California, Berkeley animal facility. Sex- and age-matched
controls were used in all experiments according to institutional guidelines for animal care. Unless
otherwise speciﬁed, 8- to 12-week-old female mice were used for all experiments.
L. monocytogenes-induced colitis. Prior to infection, 5 mg/ml of streptomycin sulfate was added to
the drinking water. After 32 h, mice were transferred to fresh cages, and chow was removed to initiate
an overnight fast. Forty-eight hours after streptomycin was added to the water, mice were isolated, fed
a 3-mm piece of bread with 3 l of butter and an inoculum of L. monocytogenes in PBS, and returned to
cages containing standard drinking water and chow. Following infection, stools were collected and
homogenized in PBS by vortexing for 5 min at 4°C, and dilutions were plated. In instances where
streptomycin was not sufﬁcient to restrict growth of intestinal bacteria, plates were supplemented with
nalidixic acid, LiCl, and glycine. To conﬁrm the identity of colonies recovered from feces, PCR for actA was
performed. To determine bacterial burden in organs, mice were euthanized and tissues were collected.
Livers were homogenized in 10 ml, while ileum (distal third of small intestines), cecum, colon, mLN, and
spleen were homogenized in 2 ml 0.1% IGEPAL CA-630 (Sigma). Gallbladders were homogenized in 2 ml
PBS. Dilutions of homogenates were plated to enumerate CFU.
STAMP. Sequence tag-based analysis of microbial populations (STAMP) analysis was performed as
previously described (11, 36). L. monocytogenes colonies were washed off plates, genomic DNA was
extracted, and the region harboring the 30-bp barcodes was ampliﬁed using primer PLM30 and primer
PLM6-P29 (see Table S1 in the supplemental material). The puriﬁed PCR products were combined in
equimolar concentrations and sequenced on an Illumina MiSeq machine using primer PLM49. Reaper-
12-340 was used to discard sequence reads with low quality (Q30) and trim the sequence following the
barcode. The trimmed sequences were clustered with QIIME (version 1.6.0) using pick_otus.py with a
sequence similarity threshold of 0.9. Genetic distance was estimated using the Cavalli-Sforza chord
distance method (37) as described by Abel et al. (36). Genetic relatedness is 1 genetic distance.
Gentamicin treatment. Cecal tissues were cut longitudinally, washed with cold PBS, and incubated
in RPMI (Gibco) containing 5% fetal calf serum, HEPES, L-glutamine, and 100 g/ml gentamicin for 45 min
at 37°C. Tissues were washed 6 times by placing the tissue into 10 ml PBS on a rotator at 4°C for 20 min.
Tissues were homogenized in 2 ml 0.01% 0.1% IGEPAL CA-630, and dilutions were plated.
Histology. For hematoxylin and eosin staining, tissues were ﬁxed in buffered 4% paraformaldehyde
(PFA). Histology was performed by HistoWiz Inc. (Brooklyn, NY) using a standard operating procedure
and fully automated workﬂow. Samples were processed, embedded in parafﬁn, and sectioned at 4 m.
After staining, sections were dehydrated and ﬁlm coverslipped using a TissueTek-Prisma and Coverslip-
per (Sakura). Whole-slide scanning (40 magniﬁcation) was performed on an Aperio AT2 (Leica Biosys-
tems). Samples were then scored by a trained pathologist blinded to the treatment group for inﬂam-
TABLE 1 Strains
Strain Description Reference or source
10403S Wild type 40
DP-L4027 Δhly (DPL-3079)-phage cured 35, 41
DP-L4029 ΔactA (DPL-2161)-phage cured 35, 42
DP-L6768 Barcoded wild-type library This study
DP-L6769 Barcoded Δhly library This study
XL1 For vector construction Stratagene
SM10 Conjugation strain 43
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mation, edema, goblet cell loss, and epithelial integrity, as previously described (38, 39) with the
following modiﬁcations to the scoring system for goblet cell loss (see Table S2). The average number of
goblet cells per high-power ﬁeld (400 magniﬁcation) was determined from 10 different regions of the
colon epithelium. Since healthy wild-type animals housed in our facilities had 18 (standard deviation
[SD], 	4) goblet cells per ﬁeld, the scoring system for goblet cell loss was adjusted accordingly. In
inﬂamed sections, scoring was taken in regions most affected. Counts were obtained only from ﬁelds
where all 4 layers of the intestine were present.
Statistical analysis. Statistical analyses were carried out with GraphPad Prism software (version 7.0a).
See ﬁgure legends for details.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.02948-19.
FIG S1, EPS ﬁle, 1.3 MB.
FIG S2, EPS ﬁle, 1.3 MB.
FIG S3, PDF ﬁle, 1 MB.
TABLE S1, PDF ﬁle, 0.1 MB.
TABLE S2, PDF ﬁle, 0.1 MB.
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